Penumbra

Traded on the St. Petersburg Stock Exchange
Penumbra is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets. Penumbra sells its products to hospitals and healthcare providers primarily in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The company is headquartered in Alameda, California, USA.
Penumbra stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Penumbra balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Penumbra cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Penumbra multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Penumbra profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Penumbra assets
Penumbra cash flows

Penumbra shares

TickerNameTypeNominal valueISINPrice
PEN:USPenumbra, Inc.Common share-US70975L1070$205.4
Penumbra news
04.05.2022
Net income of Penumbra under GAAP for the 3 months of 2022 was $0.079 million, down many times from $10.926 million in the previous year. Revenue increased 20.5% to $203.895 million from $169.204 million a year earlier.
Source: investors.penumbrainc.com pictogram investors.penumbrainc.com
Pictogram next
23.02.2022
Penumbra's GAAP net income for 2021 was $2.623 million, compared to a loss of $19.257 million the previous year. Revenue increased 33.4% to $747.59 million from $560.412 million a year earlier.
Source: investors.penumbrainc.com pictogram investors.penumbrainc.com
Pictogram next
04.11.2021
Penumbra reported a GAAP net profit of $27.256 million for 9M2011, compared to a loss of $21.889 million in the previous year. Revenues increased 38.1% to $543.579 million from $393.514 million a year earlier.
Source: investors.penumbrainc.com pictogram investors.penumbrainc.com
Pictogram next
09.08.2021
Penumbra' GAAP net income for 6M 2021 was $19.225 mln, compared to a loss of $12.013 mln in the previous year. Revenue increased 45.8% to $353.462 million from $242.438 million a year earlier.
Source: investors.penumbrainc.com pictogram investors.penumbrainc.com
Pictogram next
All Penumbra news
General information
Company namePenumbra
Tags#medtech
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business addressONE PENUMBRA PLACE ALAMEDA CA 94502 (510) 995-2486
Mailing addressONE PENUMBRA PLACE ALAMEDA CA 94502
Websitewww.penumbrainc.com
Information disclosurewww.sec.gov